- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30437
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
Hepatology. 2018 Nov 1. doi: 10.1002/hep.30339. [Epub ahead of print]
Smoking and Hepatitis B Virus-Related Hepatocellular Carcinoma Risk: The Mediating Roles of Viral Load and Alanine Aminotransferase.
Wang YH1,2, Chuang YH3, Wu CF1, Jan MC1,4, Wu WJ1, Lin CL5, Liu CJ6, Yang YC3, Chen PJ6, Lin SM7, Tsai MH8, Huang YW9, Yu MW1.
Author information
1
Graduate Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
2
Medical Research Center, Cardinal Tien Hospital and School of Medicine, College of Medicine, Fu-Jen Catholic University, New Taipei City, Taiwan.
3
Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan.
4
Department of Laboratory Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
5
Department of Gastroenterology, Ren-Ai Branch, Taipei City Hospital, Taipei, Taiwan.
6
Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital and Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
7
Division of Hepatology, Liver Research Unit, Department of Gastroenterology and Hepatology, College of Medicine, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan.
8
Institute of Biotechnology, National Taiwan University, Taipei, Taiwan.
9
Division of Gastroenterology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Abstract
Smoking interacts with hepatitis B virus (HBV) to increase risk of hepatocellular carcinoma (HCC) that might be explained by its role in antiviral immunity. We aimed to evaluate the potential mediating role of viral load and/or alanine aminotransferase (ALT) in the relation of smoking with HBV-associated HCC risk. Using multiple mediation analyses to analyze data from 209 HCC cases and 1256 controls nested within a cohort of 4841 male HBV carriers, we found that the effect of smoking on the risk of subsequent HCC was substantially mediated through viral load (percent mediated= 31.7%; P=0.0054), and a significant mediation effect by both viral load and ALT was also evidenced. Among the 1143 subjects with repeated measures of viral load and ALT over periods of up to 16 years, we further observed that higher pack-years of smoking was associated with higher viral load, maintenance of a high viral load (>4.39 log copies/mL), severer hepatotoxicity grades, and increased likelihood of ALT ≥80 U/L (odds ratio [95% CI]: 3.14 [1.03-9.64] and 6.06 [1.10-33.25], respectively, for 10-19 and ≥20 pack-years vs. nonsmokers) during follow-up. Furthermore, plasma interferon-γ levels were reduced in smokers compared with nonsmokers (interferon-γ-positive rate: 14.9% vs. 28.7%, P<0.0001) at baseline. Smoking was also associated with a reduced natural killer (NK) cell frequency in peripheral blood, characterized by reduced NK function through a systems immunology approach, after long-term follow-up in a subsample (N=171). The combination of smoking and reduced NK cell frequency further increased viral load and the likelihood of occurring ALT ≥80 U/L. Conclusion The data highlight a role of smoking on HBV viral load, underlining the importance of smoking prevention and cessation in hepatitis B management. This article is protected by copyright. All rights reserved.
KEYWORDS:
longitudinal study; mediation analysis; natural killer cells; plasma interferon-γ levels; transcriptome
PMID:
30382583
DOI:
10.1002/hep.30339
|
|